Navigation Links
Cloned stem cells prove identical to fertilized stem cells

Scientists generally agree that all cloned animals are biologically flawed. But they don't agree about what that means for stem cells derived from cloned embryos, the basis for therapeutic cloning.

Also known as somatic cell nuclear transfer, therapeutic cloning is a promising approach to create individually customized cellular therapies for treating certain disorders. Demonstrated in mice but not in humans, it begins with stem cells derived from a cloned embryo. But if cloned embryos can't produce normal organisms, how can they produce normal stem cells?

Analyzing the complete gene-expression profiles of both cloned and fertilization-derived stem cells in mice, scientists at Whitehead Institute for Biomedical Research now have concluded that the two are, in fact, indistinguishable.

"This paper demonstrates clearly that it doesn't matter if a stem cell has been derived from a cloned embryo or from a fertilized embryo," says Whitehead Member Rudolf Jaenisch, senior author on the paper that will appear in the online the week of January 16 in the Proceedings of the National Academy of Sciences. "Both can be equally good for therapy."

To create a clone, a scientist removes the nucleus from a donor cell, then places it into an egg from which the nucleus has been removed. The researcher then tricks the egg into thinking it's been fertilized. The egg develops into a blastocyst, an early stage embryo consisting of no more than 100 or so cells. The scientist can then either remove the stem cells from this blastocyst, or place it into a uterus where it has the potential to develop into a fetus.

Here's where things get complicated. The original donated nucleus may have come from, say, a skin cell. For a viable fetus to develop, the egg needs to reprogram the genome of the skin cell, shutting off genes specific for skin tissue and turning on genes needed for embryonic development, genes that are normally dormant in tissue-specific cells
'"/>

Source:Whitehead Institute for Biomedical Research


Page: 1 2 3

Related biology news :

1. Cloned mice created from fully differentiated cells, a milestone in cloning research
2. Wisconsin scientists grow critical nerve cells
3. Spleen may be source of versatile stem cells
4. Researchers discover way to make cells in the eye sensitive to light
5. Priming embryonic stem cells to fulfill their promise
6. Lack of enzyme turns fat cells into fat burners
7. Poor prenatal nutrition permanently damages function of insulin-producing cells in the pancreas
8. Elusive HIV shape change revealed; Key clue to how virus infects cells
9. Mouse brain cells rapidly recover after Alzheimers plaques are cleared
10. Enzyme allows B cells to resist death, leading to leukemia
11. Scientists rid stem cell culture of key animal cells

Post Your Comments:
(Date:11/24/2009)..., Rocket science is opening new doors to understa...affect the hearing of a marine mammal or if they ...ial sized X-ray scanners that NASA uses to detect ...ockets is now allowing scientists to peek inside t...detailed three-dimensional replicas of a whale,s h...
(Date:11/24/2009)..., Stents that keep weakened and flabby arteries f...er six months, those stents are no longer needed -...unnecessary. Previously, doctors had no choice but...n of Tel Aviv University,s Department of Biomedica...iber platform that carries drugs where they,re nee...
(Date:11/24/2009)..., Springer and the American College of Medical To...orate on the publication of the Journal of Medica...CMT, beginning in March 2010. It was previously p... , The Journal of Medical Toxicology , an inter...dvancing the science and practice of medical toxic...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2A coating for life 2Springer and the American College of Medical Toxicology to work together 2RCRC Independent Review Board Announces DHHS Research Oversight 58331 1RCRC Independent Review Board Announces DHHS Research Oversight 58331 2New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 1New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 2New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 3New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 4New Invacare SOLO2 Portable Oxygen Concentrator Available At Vitality Medical 58329 5Social background weighs heavily on teenage diet 58327 1Social background weighs heavily on teenage diet 58327 2
...nt deadly outbreak of equine herpes virus at Churc...University virologist says his preliminary researc... viruses, called modified live vaccines (MLV), app...s than other more widely used vaccines. , "It,s im...use for decades, has proven to be reasonably safe,...
...suspect version of a gene may slightly increase ri...aging study by the National Institutes of Health,s... The gene variant produced a telltale pattern of a...ger chemical. , The study found that increased act...s in the neurotransmitter dopamine in the middle o...
...University of Liverpool have discovered how the pl...uropeans resistant to HIV. Scientists have known f...c mutation (known as CCR5-delta32) that prevents t...tem but have been unable to account for the high l...w levels in areas bordering the Mediterranean. , T...
Other Biology News:Live vaccines more effective against horse herpes virus 2Live vaccines more effective against horse herpes virus 3Brain Scans Reveal How Gene May Boost Schizophrenia Risk 2Brain Scans Reveal How Gene May Boost Schizophrenia Risk 3First North American Encapsulated Islet Transplant without Long-term Immune Suppression into a Patient with Type 1 Diabetes 2
(Date:11/24/2009)...lue Marble Energy Corp. announced today that the c... (OPDA) were recently awarded $2 million by Washin...rd (CERB) in a private/public partnership to const...finery in Lincoln County, WA. ,, "This invest...ur biorefinery and bring over 70 green jobs to Lin...
(Date:11/24/2009)...s been met for patients with advanced-stage, or... Nov. 24 /PRNewswire-FirstCall/ - AEterna Zentaris...a global biopharmaceutical company focused on endo...ve efficacy data from a Phase 2 study with its tar...rly AN-152), in patients with advanced or recurren...
(Date:11/24/2009)...re-FirstCall/ -- Shire plc (LSE: SHP,NASDAQ: SHP...ny, today,announced that it has submitted a MAA to...lfa, the company,s enzyme replacement therapy in d...ease. This is the third marketing,application for ...revious,submissions in the United States and Canad...
(Date:11/24/2009)...RNewswire-FirstCall/ -- Genomic Health, Inc. (Nasd...mic Health,s Executive Chairman, will present at t...e in New York City on Tuesday, December 1, 2009 at...equently archived webcast of the presentation, vis...h,s website at http://investor.genomichealth.com ...
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...ith SciQuest will Save Time and Money, OAK BROOK,...hSystem Consortium (UHC), an alliance of academic ... SciQuest, a provider of e-procurement,technology ...anizations,today announced a partnership to provid... Research Procurement Program with a robust, easy-...
..., Oct. 9 Boston Scientific,Corporation (NYSE: BS...NT(TM) implantable cardioverter defibrillator (ICD...tific-branded cardiac rhythm management,device to ...D, with an enhanced AV Search Hysteresis feature, ...r pacing. This product also,contains wireless capa...
...l Advance Development of Diagnostics and Disease-M...d Macular Degeneration and Other Diseases ...W HAVEN, Conn., Oct. 9 Optherion, Inc., a company... wet Age-related Macular,Degeneration (AMD) and ot...plement system, announced today that it has raised...
Other Biology Technology:University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 2University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 3Boston Scientific Announces European Approval of Next-Generation Implantable Defibrillator 2Boston Scientific Announces European Approval of Next-Generation Implantable Defibrillator 3Optherion, Inc. Completes $37 Million Start Up Financing 2Optherion, Inc. Completes $37 Million Start Up Financing 3Optherion, Inc. Completes $37 Million Start Up Financing 4
Rabbit Anti-DAP12 Polyclonal Antibody, Unconjugated from Exalpha Biologicals, Inc.
Mouse Anti-S100 alpha Monoclonal Antibody, Unconjugated, Clone SH-A1 from Abcam
Calf Liver tRNA from Novagen
Anti-Taste Receptor 2 (TR2) Polyclonal Antibody, Unconjugated from CHEMICON
Biology Products: